Expand SRPT Menu
SRPT MENU

SRPT Stock Posts


Upcoming Earnings

SRPT Sarepta Therapeutics19.04+0.20 (+1.1%)

Sarepta Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±7.5% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±18.8%. View Expected Move (Conf Call: Feb 25 4:30 PM)
SRPT #SareptaTherapeutics stock increases 9.6% after hours.

After Hours Gainer

SRPT Sarepta Therapeutics21.13-0.66-3.0%

After Hours:23.17+2.04 (+9.7%)

Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy

Business WireFri, 23-Jan 4:05 PM
SRPT #SareptaTherapeutics stock increases 8.8% after hours.

After Hours Gainer

SRPT Sarepta Therapeutics21.13-0.66-3.0%

After Hours:23.00+1.87 (+8.9%)

Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy

Business WireFri, 23-Jan 4:05 PM

SRPT 20.83-3.00 (-12.6%)Sarepta Therapeutics

  • ATM straddle for 16-Jan-26 expiration returned a positive 52.1% from the previous business day
  • The upside wing (25 delta calls) declined -58.8%
  • Downside put (25 delta puts) gained 347.1%
  • The company has the following event: 44th Annual J.P. Morgan Healthcare Conference on Jan 12, 2026.
  • The option volume for 16-Jan-26 expiration is 5,045
  • News: Sarepta Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues
Unusual Option Volume

SRPT Sarepta Therapeutics17.48-6.97 (-28.5%)

Sarepta Therapeutics trades 13,318 contracts. News: Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
View Details...
Upcoming Earnings

SRPT Sarepta Therapeutics23.62-0.39 (-1.6%)

Sarepta Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±17.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±13.7%. View Expected Move (Conf Call: Nov 3 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes